Oak Ridge Investments’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Oak Ridge Investments’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,841,298	Closed	-$14.7M	–	157
2015 Q2	$14.7M	Buy	1,841,298 +1,388	+0.1%	+$11.9K	0.31%	80
2015 Q1	$19.3M	Buy	1,839,910 +4,686	+0.3%	+$64K	0.43%	70
2014 Q4	$22.1M	Buy	1,835,224 +3,629	+0.2%	+$55.1K	0.53%	60
2014 Q3	$31.3M	Buy	1,831,595 +445,368	+32%	+$6.46M	0.82%	45
2014 Q2	$16.7M	Buy	+1,386,227	New	+$13.1M	0.4%	75

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Oak Ridge Investments's BDSI Position: Q3 2015 in Review

Oak Ridge Investments sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2015, closing a stake of 1,841,298 shares — an estimated $14.7M sold.

Oak Ridge Investments first reported a position in BDSI in Q2 2014 and held it in 5 quarters. The position peaked at $31.3M in Q3 2014. 131 funds tracked by Wall St. Rank hold BDSI as of Q3 2015.

Oak Ridge Investments reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2015 after selling out during the quarter.
Oak Ridge Investments sold 1,841,298 BioDelivery Sciences International, Inc. shares in Q3 2015, an estimated $14.7M.
Oak Ridge Investments first reported a position in BioDelivery Sciences International, Inc. in Q2 2014 and held it in 5 quarters.
Oak Ridge Investments's BioDelivery Sciences International, Inc. position peaked at $31.3M in Q3 2014.
131 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2015.

Based on Oak Ridge Investments's 13F filing for Q3 2015, filed 3 Nov 2015.